Growth Metrics

Medicale (MCLE) Cash & Equivalents (2021 - 2024)

Medicale (MCLE) has disclosed Cash & Equivalents for 4 consecutive years, with $159.0 as the latest value for Q4 2024.

  • For the quarter ending Q4 2024, Cash & Equivalents changed 0.0% year-over-year to $159.0, compared with a TTM value of $159.0 through Dec 2024, changed 0.0%, and an annual FY2024 reading of $159.0, changed 0.0% over the prior year.
  • Cash & Equivalents was $159.0 for Q4 2024 at Medicale, roughly flat from $159.0 in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $23900.0 in Q1 2021 and bottomed at $159.0 in Q4 2022.
  • Average Cash & Equivalents over 4 years is $4878.6, with a median of $159.0 recorded in 2022.
  • The sharpest move saw Cash & Equivalents tumbled 98.56% in 2022, then changed 0.0% in 2023.
  • Year by year, Cash & Equivalents stood at $3379.0 in 2021, then tumbled by 95.29% to $159.0 in 2022, then changed by 0.0% to $159.0 in 2023, then changed by 0.0% to $159.0 in 2024.
  • Business Quant data shows Cash & Equivalents for MCLE at $159.0 in Q4 2024, $159.0 in Q3 2024, and $159.0 in Q2 2024.